Jerónimo Martins, SGPS (OTCMKTS:JRONY - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.53 earnings per share for the quarter, missing analysts' consensus estimates of $0.54 by ($0.01), Zacks reports. Jerónimo Martins, SGPS had a net margin of 1.94% and a return on equity of 21.07%.
Jerónimo Martins, SGPS Price Performance
Shares of OTCMKTS:JRONY traded down $0.80 during trading on Friday, reaching $41.41. The stock had a trading volume of 2,826 shares, compared to its average volume of 10,259. Jerónimo Martins, SGPS has a 52 week low of $32.68 and a 52 week high of $45.41. The business's 50-day moving average price is $41.36 and its 200 day moving average price is $39.23. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.56 and a quick ratio of 0.30. The stock has a market capitalization of $13.03 billion, a PE ratio of 18.65, a P/E/G ratio of 15.69 and a beta of 0.68.
About Jerónimo Martins, SGPS
(
Get Free Report)
Jerónimo Martins, SGPS, SA operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia.
Recommended Stories
Before you consider Jerónimo Martins, SGPS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jerónimo Martins, SGPS wasn't on the list.
While Jerónimo Martins, SGPS currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
